Edesa Biotech Inc reports results for the quarter ended in December - Earnings Summary

Edesa Biotech

09/02/2024 23:18

* Edesa Biotech Inc  EDSA.OQ  reported a quarterly adjusted
loss
of 54 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -91 cents.  The mean expectation of two analysts
for the quarter was for a loss of $1.21 per share. Wall Street
expected results to range from $-1.62 to -80 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Edesa Biotech Inc's reported EPS for the quarter was a
loss
of 54 cents​.
    * The company reported a quarterly loss of $1.68 million.
    * Edesa Biotech Inc shares had risen by 2.2% this quarter.

FORECAST CHANGES
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Edesa Biotech Inc
is $21.00 
This summary was machine generated from LSEG data February 9 at
11:18 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -1.21          -0.54          Beat
 Sep. 30 2023      -0.71          -0.60          Beat
 Jun. 30 2023      -1.21          -0.70          Beat
 Mar. 31 2023      -1.21          -0.84          Beat